Page last updated: 2024-10-23

benzbromarone and Dyslipidemia

benzbromarone has been researched along with Dyslipidemia in 1 studies

Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.

Research Excerpts

ExcerptRelevanceReference
"Therefore, 35."1.51Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients. ( Fuller, R; Goldenstein-Schainberg, C; Hoff, LS, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoff, LS1
Goldenstein-Schainberg, C1
Fuller, R1

Other Studies

1 other study available for benzbromarone and Dyslipidemia

ArticleYear
Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients.
    Advances in rheumatology (London, England), 2019, 12-31, Volume: 60, Issue:1

    Topics: Adult; Asymptomatic Diseases; Benzbromarone; Brazil; Cross-Sectional Studies; Diabetes Mellitus; Diu

2019
chemdatabank.com